Mona Alfaraj: Therapeutic Apheresis Case Series in Sickle Cell Disease with Fat Embolism Syndrome
Mona Alfaraj, Consultant Hematopathologist and Transfusionist, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Hemoglobin:
“Happy to share that one of our works on therapeutic apheresis has been published. Grateful for the collaboration and the opportunity to contribute in a scientific work that supports better patient care. Proud of the team and the journey behind this work.
For those with trasfusion and apheresis interest, it is worth to emphasize that although plasma is the standard replacement fluid in TPE for FES, a 50:50 replacement protocol using FFP and 5% human albumin was used in both reported cases. This approach aligns with ASFA guidelines , which recommend limiting full FFP replacement to conditions with clear coagulopathy or high bleeding risk.
In sickle cell disease, this mixed replacement strategy aims to reduce donor plasma exposure while ensuring that the FFP provided is sufficient to address any preexisting or exchange-induced coagulopathy.
A similar protocol has been used in other studies involving critically ill patients with sickle cell disease and multi organ failure.
This case series is a step of greater project of optimum utilization of plasma in therapeutic plasma exchange .”
Title: Therapeutic Plasma Exchange as a Rescue Therapy in Sickle Cell Disease-Associated Fat Embolism Syndrome: Case Series and Literature Review
Authors: Abdulmohsen K. Aljishia, Fatimah A. Alrabia, Abdullah M. Al Abbas, Mona M. Alfaraji, Fadhel A. Alomard, Salah Abohelaikac
Read the Full Article on Hemoglobin
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics